延迟药物过敏反应:p-i如何将药理学转化为免疫学
1ADR-AC GmbH, Holligenstr. 91, 3008 Bern, Switzerland.
概括
延迟药物过敏反应 (dDHRs) 不是过敏,而是特有的T细胞激活. 与免疫受体 (p-i) 机制的药理相互作用解释了dDHRs,将其与经典免疫反应区分开来.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- T细胞生物学T细胞生物学
背景情况:
- 延迟药物过敏反应 (dDHRs) 是一种阳性疾病.
- 这些反应主要是由与免疫受体 (如HLA和TCR) 的药物相互作用引起的,导致T细胞激活.
- 这种相互作用被称为与免疫受体 (p-i) 的药理相互作用.
研究的目的:
- 阐明在dDHR中p-i激活的独特机制.
- 为了区分p-i激活与经典的抗原驱动免疫反应.
- 突出了解p-i对dDHR预防和治疗的影响.
主要方法:
- 这项研究侧重于p-i激活和抗原驱动的免疫反应之间的机制差异.
- 对TCR-HLA复合体中药物诱导的结构变化的分析.
- 研究改变的TCR-HLA相互作用亲和力和下游信号的研究.
主要成果:
- P-i激活会诱导类似的T细胞刺激,其特点是细胞毒性和IFNγ产生,独立于先天免疫.
- 药物结合可以增强TCR-HLA亲和力,影响IL-5的产生和eosinophilia,并可能导致T细胞扩张.
- 皮-i刺激可以导致长期的T细胞激活,类似于移植对宿主反应,可能导致病毒病,自身免疫或多种药物过敏症 (MDH).
结论:
- dDHRs是特有的T细胞激活,而不是过敏反应,由p-i机制驱动.
- 了解p-i激活对于开发预防策略和有效治疗dDHRs至关重要.
- 这种机制为TCR信号传递,全活性和潜在的新型免疫刺激方法提供了洞察力.
相关概念视频
Allergic Drug Reactions
818
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
818
Hypersensitivities
550
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
550
Pharmacodynamics: Overview and Principles
986
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
986
Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.2K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.2K
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K


